BELITE BIO, INC (BLTE) has 4 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 4 sales totalling $32.0M. Most recent filing: Sept. 9, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 9, 2026 filed Sept. 4, 2026 | Lin Yu-Hsin Chief Executive Officer | −$19,082,549 | 100,435 | −59% | Yes | |
|
|
||||||
| Sept. 9, 2026 filed Sept. 4, 2026 | Chuang Hao-Yuan Chief Financial Officer | −$12,803,528 | 67,395 | −72% | Yes | |
|
|
||||||
| Aug. 14, 2026 filed Aug. 12, 2026 | Chuang Hao-Yuan Chief Financial Officer | −$66,187 | 367 | −0% | Yes | |
|
|
||||||
| Aug. 14, 2026 filed Aug. 12, 2026 | Lin Yu-Hsin Chief Executive Officer | −$65,827 | 365 | −0% | Yes | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free